Vigabatrin Tablet
Product Images NDC 69238-1424

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 69238-1424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Vigabatrin Tablets 1)

Formula (Vigabatrin Tablets 1)
Chemical structure of Vigabatrin, showing the molecular arrangement including an amino group, a carboxylic acid group, and a vinyl side chain, consistent with its chemical identity as an antiepileptic agent.*
FDA Label Image

Figure 1 (Vigabatrin Tablets 2)

Figure 1 (Vigabatrin Tablets 2)
A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' showing percentage reduction in seizure frequency on the vertical axis (ranging from -100 to 100) against percentage of patients on the horizontal axis (100 to 0). It includes multiple dose groups for Vigabatrin (1g/day, 3g/day, 6g/day) and a placebo, illustrating patient response with improvement above zero and worsening below zero in seizure frequency.*
FDA Label Image

Figure 2 (Vigabatrin Tablets 3)

Figure 2 (Vigabatrin Tablets 3)
A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' displaying percentage reduction in seizure frequency on the vertical axis and percentage of patients on the horizontal axis. Two lines represent placebo and 3g/day Vigabatrin (VGB), illustrating the distribution of patients by seizure reduction, with annotations for improvement, no change, and worsening.*
FDA Label Image

500 mg 100ct Label (Vigabatrin Tablets 4)

500 mg 100ct Label (Vigabatrin Tablets 4)
Label for Vigabatrin Tablets, USP 500 mg oral tablets distributed by Amneal Pharmaceuticals LLC. The label includes the NDC 69238-1424-1, storage instructions at 20° to 25°C, and note to dispense with Medication Guide. The package contains 100 tablets and is labeled for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.